Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Oh WK, Kantoff PW, Weinberg V, Jones G, Rini BI, Derynck MK, Bok R, Smith MR, Bubley GJ, Rosen RT, DiPaola RS, Small EJ. Oh WK, et al. Among authors: rini bi. J Clin Oncol. 2004 Sep 15;22(18):3705-12. doi: 10.1200/JCO.2004.10.195. Epub 2004 Aug 2. J Clin Oncol. 2004. PMID: 15289492 Clinical Trial.
An update on prostate cancer.
Rini BI, Small EJ. Rini BI, et al. Curr Opin Oncol. 2001 May;13(3):204-11. doi: 10.1097/00001622-200105000-00013. Curr Opin Oncol. 2001. PMID: 11307066 Review.
Immunotherapy for prostate cancer.
Rini BI, Small EJ. Rini BI, et al. Curr Oncol Rep. 2001 Sep;3(5):418-23. doi: 10.1007/s11912-001-0028-1. Curr Oncol Rep. 2001. PMID: 11489243 Review.
Prostate cancer update.
Rini BI, Small EJ. Rini BI, et al. Curr Opin Oncol. 2002 May;14(3):286-91. doi: 10.1097/00001622-200205000-00006. Curr Opin Oncol. 2002. PMID: 11981273 Review.
Hormone-refractory Prostate Cancer.
Rini BI, Small EJ. Rini BI, et al. Curr Treat Options Oncol. 2002 Oct;3(5):437-46. doi: 10.1007/s11864-002-0008-1. Curr Treat Options Oncol. 2002. PMID: 12194808 Review.
The potential for prostate cancer immunotherapy.
Rini BI, Small EJ. Rini BI, et al. Crit Rev Oncol Hematol. 2003 Jun 27;46 Suppl:S117-25. doi: 10.1016/s1040-8428(03)00069-6. Crit Rev Oncol Hematol. 2003. PMID: 12850532 Review.
519 results